Mainstream Capital Management »

Pyxis Oncology shares owned by Mainstream Capital Management

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by Mainstream Capital Management from 13F filings

Historical chart of Mainstream Capital Management investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by Mainstream Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by Mainstream Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $312 200 1.56

More positions owned by Mainstream Capital Management

Jpmorgan Ultra-short Income Etf Etf (JPST)
Apple Stock (AAPL)
Amazon Stock (AMZN)
Goldman Sachs Ultra Short Bond Etf Etf (GSST)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Nvidia Corporation Stock (NVDA)
Meta Platforms Inc Cl A Stock (META)
Ishares Russell 1000 Growth Etf Etf (IWF)
Ishares Russell 1000 Value Etf Etf (IWD)
Ishares Core S&p 500 Etf Etf (IVV)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Tesla Stock (TSLA)
Microsoft Corp Stock (MSFT)

View all positions for Mainstream Capital Management

Top funds holding Pyxis Oncology

Pfizer
Laurion Capital Management
Tang Capital Management
Vanguard Group
Perceptive Advisors
Palo Alto Investors
Millennium Management
Stempoint Capital
BlackRock
Renaissance Technologies
Geode Capital Management
683 Capital Management
Driehaus Capital Management
UBS Group
Citadel Advisors

View all funds holding Pyxis Oncology